Literature DB >> 22940767

Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.

N P Polyzos1, C Blockeel, W Verpoest, M De Vos, D Stoop, V Vloeberghs, M Camus, P Devroey, H Tournaye.   

Abstract

STUDY QUESTION: What is the effect of natural cycle IVF in women with poor ovarian response according to the new ESHRE definition for poor ovarian responders: the Bologna criteria? SUMMARY ANSWER: Although natural cycle IVF is a promising treatment option for normal responders, poor ovarian responders, as described by the Bologna criteria, have a very poor prognosis and do not appear to experience substantial benefits with natural cycle IVF. WHAT IS KNOWN ALREADY: Previous trials have shown that natural cycle IVF is an effective treatment for the general infertile population and might be an option for poor ovarian responders. However, none of the trials have examined the effect of natural cycle IVF in poor responders according to the Bologna criteria, the newly introduced definition by the ESHRE Working Group on Poor Ovarian Response Definition. In this trial, we examined the effect of natural cycle IVF in poor ovarian responders fulfilling the Bologna criteria. STUDY DESIGN, SIZE, DURATION: In this retrospective cohort trial, 164 consecutive patients, undergoing 469 natural cycle IVFs between 2008 and 2011 were included. Patients were stratified as poor and normal responders: 136 (390 cycles) were poor ovarian responders according to the Bologna criteria, whereas 28 women (79 treatment cycles) did not fulfil the criteria and were considered as normal responders. PARTICIPANTS/MATERIALS, SETTING,
METHODS: All patients were monitored with hormonal analysis and ultrasound scan every second day, from Day 7 or 8 of the cycle onwards. When a follicle of >16 mm was observed, ovulation was triggered with 5000 IU of i.m. hCG and oocyte retrieval was performed 32 h later. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth rates in poor responders according to the Bologna criteria were significantly lower compared with the control group of women; the live birth rate per cycle was 2.6 versus 8.9%, P = 0.006 and the live birth rate per treated patient was 7.4 versus 25%, P = 0.005. In poor responders according to the Bologna criteria, live birth rates were consistently low and did not differ among different age groups (≤ 35 years, 36-39 years and ≥ 40 years), with a range from 6.8 to 7.9%. LIMITATIONS, REASONS FOR CAUTION: A limitation of our analysis is its retrospective design; however, taking into account that we included only consecutive patients treated with exactly the same protocol, the likelihood of selection bias might be considerably limited. In addition, the control group in our study refers to women of younger age and therefore the promising results among patients who did not fulfil the Bologna criteria apply only to women of younger age. WIDER IMPLICATIONS OF THE
FINDINGS: Our trial suggests that although natural cycle IVF is a promising treatment option for younger normal responders, its potential is very limited to poor ovarian responders as described by the Bologna criteria, irrespective of patient's age. This highlights the very poor prognosis of these women and therefore the urgent need for future trials to examine the effect of ovarian stimulation protocols in women with poor ovarian response as described by the Bologna criteria. STUDY FUNDING/COMPETING INTEREST(S): No funding was used. There are no competing interests to declare.

Entities:  

Mesh:

Year:  2012        PMID: 22940767     DOI: 10.1093/humrep/des318

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  33 in total

1.  Cumulative live birth rate after three ovarian stimulation IVF cycles for poor ovarian responders according to the bologna criteria.

Authors:  Hui Ke; Xin Chen; Yu-Dong Liu; De-Sheng Ye; Yu-Xia He; Shi-Ling Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

2.  Accumulation of oocytes from a few modified natural cycles to improve IVF results: a pilot study.

Authors:  Ermanno Greco; Katarzyna Litwicka; Cristiana Arrivi; Maria Teresa Varricchio; Daniela Zavaglia; Cecilia Mencacci; Maria Giulia Minasi
Journal:  J Assist Reprod Genet       Date:  2013-11       Impact factor: 3.412

3.  Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders according to the Bologna criteria.

Authors:  Linli Hu; Zhiqin Bu; Yihong Guo; Yingchun Su; Jun Zhai; Yingpu Sun
Journal:  Int J Clin Exp Med       Date:  2014-04-15

4.  Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.

Authors:  Kate Devine; Sunni L Mumford; Mae Wu; Alan H DeCherney; Micah J Hill; Anthony Propst
Journal:  Fertil Steril       Date:  2015-06-11       Impact factor: 7.329

5.  Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience.

Authors:  Talya Shaulov; Maria P Vélez; Karen Buzaglo; Simon J Phillips; Isaac Jacques Kadoch
Journal:  J Assist Reprod Genet       Date:  2015-06-04       Impact factor: 3.412

6.  Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective in Women with Impending Ovarian Failure and Diminished Ovarian Reserve.

Authors:  Chao-Chin Hsu; Isabel Hsu; Li-Hsuan Lee; Yuan-Shuo Hsueh; Chih-Ying Lin; Hui Hua Chang
Journal:  Biomedicines       Date:  2022-06-03

7.  Total fertilization failure: is it the end of the story?

Authors:  Inci Kahyaoglu; Berfu Demir; Ayten Turkkanı; Ozgur Cınar; Serdar Dilbaz; Berna Dilbaz; Leyla Mollamahmutoglu
Journal:  J Assist Reprod Genet       Date:  2014-06-25       Impact factor: 3.412

8.  Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved.

Authors:  Ioannis A Sfontouris; Efstratios M Kolibianakis; George T Lainas; Ram Navaratnarajah; Basil C Tarlatzis; Trifon G Lainas
Journal:  J Assist Reprod Genet       Date:  2015-03-11       Impact factor: 3.412

9.  Delayed Start Protocol with Gonadotropin-releasing Hormone Antagonist in Poor Responders Undergoing In Vitro Fertilization: A Randomized, Double-blinded, Clinical Trial.

Authors:  Afsoon Zarei; Mohammad Ebrahim Parsanezhad; Maryam Azizi Kutenaei; Bahia Namavar Jahromi; Parastoo Soheil Esfahani; Pardis Bakhshaei
Journal:  Oman Med J       Date:  2018-11

10.  Corifollitropin α followed by menotropin for poor ovarian responders' trial (COMPORT): a protocol of a multicentre randomised trial.

Authors:  Nikolaos P Polyzos; Michel Camus; Joaquin Llacer; Konstantinos Pantos; Herman Tournaye
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.